Scope Fluidics mulls NewConnect IPO

Healthcare start-up Scope Fluidics is preparing to enter small-cap, alternative NewConnect market, the company said in a market filing. The company has already started the process of publishing regular market filings, after being granted the access to the Electronic Information Base (EIB), by the WSE. The company wants to float 2.16 million of its B and C series shares. The non-public offering of C shares was carried out in the first half of the year at an issue price of PLN 18. Scope Fluidics is involved in the development of technology projects in the field of diagnostics and healthcare.